# Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

> **NCT01018836** · PHASE1 · TERMINATED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 9 (actual)

## Conditions studied

- Metastatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** riluzole
- **RADIATION:** whole-brain radiation therapy

## Key facts

- **NCT ID:** NCT01018836
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2014-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018836, "Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01018836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*